Hepatoprotective effects of aqueous extract from lingzhi or reishi medicinal mushroom Ganoderma lucidum (Higher Basidiomycetes) on α-amanitin-induced liver injury in mice

International Journal of Medicinal Mushrooms

Volumn 15, Issue 4, 2013, Pages 383-391

  Wu, Xin ^a   Zeng, Jun ^a   Hu, Jinsong ^a,b   Liao, Qiong ^a   Zhou, Rong ^a   Zhang, Ping ^a   Chen, Zuohong ^a  

^a HUNAN NORMAL UNIVERSITY   (China)

^b UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

amanitin; Antioxidant; Ganoderma lucidum; Hepatoprotective effect; Medicinal mushrooms

Indexed keywords

ALPHA AMANITIN; CATALASE; FUNGAL EXTRACT; GANODERMA LUCIDUM EXTRACT; MALONALDEHYDE; SILIBININ; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHEMICAL ANALYSIS; CONTROLLED STUDY; FEMALE; GANODERMA LUCIDUM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; LETHAL DOSE; LIVER HOMOGENATE; LIVER INJURY; LIVER PROTECTION; MALE; MICROPHOTOGRAPHY; MORTALITY; MOUSE; NONHUMAN; SCAVENGING SYSTEM;

ALPHA-AMANITIN; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG-INDUCED LIVER INJURY; FEMALE; GANODERMA; MALE; MICE; RANDOM ALLOCATION;

AMANITA EXITIALIS; BASIDIOMYCOTA; GANODERMA LUCIDUM; MUS;

EID: 84879060882     PISSN: 15219437     EISSN: 19404344     Source Type: Journal    
DOI: 10.1615/IntJMedMushr.v15.i4.60     Document Type: Article

References (32)

1. Enjalbert F, Rapior S, Nouguier-Soule J, Guillon S, Amoroux N, Cabot C. Treatment of amatoxin poisoning: 20-year retrospective analysis. J Toxicol Clin Toxicol. 2002;40:715-57.
2. Yang ZL. Amanitaceae. Flora Fungorum Sinicorum 27. Beijing: Science Press; 2005.
3. Wieland T. Peptides of poisonous Amanita mushrooms. New York: Springer; 1986.
4. Nguyen VT, Giannoni F, Dubois MF, Seo SJ, Vigeneron M, Kédinger C, Bensaude O. In vivo degradation of RNA polymerase II largest subunit triggered by alpha amanitin. Nucleic Acids Res. 1996;24:2924-29.
5. Rudd M, Luse D. Amanitin greatly reduces the rate of transcription by RNA polymerase II ternary complexes but fails to inhibit some transcript cleavage modes. J Biol Chem. 1996;271:21549-58.
6. Christine KS, Hans P. Cytotoxic fungi-an overview. Toxicology. 2003;42:339-49.
7. Spoerke DG, Rumack BH. Handbook of mushroom poisoning: diagnosis and treatment. Boca Raton: CRC Press;1994.
8. Berger KJ, Guss DA. Mycotoxins revisited: part I. J Emerg Med. 2005;28:53-62.
9. Magdalan J, Ostrowska A, Piotrowska A, Gomulkiewicz A, Szelag A, Dziegiel P. Comparative antidotal efficacy of benzylpenicyllin, ceftazidime and rifamycin in cultured human hepatocytes intoxicated with α-amanitin. Arch Toxicol. 2009;83:1091-96.
10. Magdalan J, Ostrowska A, Piotrowska A, Gomuikiewicz A, Podhorska-Okoiów M, Patrzaiek D, Szelag A, Dzidgiel P. Benzylpenicillin, acetylcysteine and silibinin as antidotes in human hepatocytes intoxicated with α-amanitin. Exp Toxicol Pathol. 2010;62:367-73.
11. Magdalan J, Piotrowska A, Gomulkiewicz A, Sozanski T, Podhorska-Okoiów M, Szelag A, Dzidgiel P. Benzylpenicyllin and acetylcysteine protection from α-amanitin-induced apoptosis in human hepatocyte cultures. Exp Toxicol Pathol. 2011;63:311-15.
12. Tong TC, Hernandez M, Richardson WH 3rd, Betten DP, Favata M, Riffenburgh RH, Clark RF, Tanen DA. Comparative treatment of α-amanitin poisoning with N-acetylcysteine, benzylpenicillin, cimetidine, thioctic acid, and silybin in a murine model. Ann Emerg Med. 2007;50:282-88.
13. Paterson RRM. Ganoderma-A therapeutic fungal biofactory. Phytochemistry. 2006;67:1985-2001.
14. Sanodiya BS, Thakur GS, Baghel RK, Prasad GBKS, Bisen PS. Ganoderma lucidum: a potent pharmacological macrofungus. Curr Pharm Biotechnol. 2009;10:717-42.
15. Boh B, Berovic M, Zhang JS, Lin ZB. Ganoderma lucidum and its pharmaceutically active compounds. Biotechnol Annu Rev. 2007;13:265-301.
16. Gao YH, Gao H, Chan EH, Tang WB, Li XT, Liang J, Zhou SF. Protective effect of Ganoderma (a mushroom with medicine properties) against various liver injuries. Food Rev Int. 2005;2005:27-52.
17. Yang XJ, Liu J, Ye LB, Yang F, Ye L, Gao JR, Wu ZH. In vitro and in vivo protective effects of proteoglycan isolated from mycelia of Ganoderma lucidum on carbon tetrachloride-induced liver injury. World J Gastroenterol. 2006;12:1379-85.
18. Wang MY, Liu Q, Che QM, Lin ZB. Effects of triterpenoids from Ganoderma lucidum (Leyss. ex Fr.) Karst. on three different experimental liver injury models in mice. Acta Pharm Sin. 2000;35:326-29.
19. Shi YL, Sun J, He H, Guo H, Zhang S. Hepatoprotective effects of Ganoderma lucidum peptides against D-galactosamine-induced liver injury in mice. J Ethnopharmacol. 2008;117:415-19.
20. He XL, He JY. The Curative effect of Ganoderma sinense on treating poisoning patients by toxic mushrooms. Acta Edulis Fungi. 1999;6:47-48.
21. Xiao GL, Zhang CH, Liu FY, Chen ZH, Hu SY. Clinical experience in treatment of Amanita mushroom poisoning with glossy Ganoderma decoction and routine western medicines. Chin J Integr Med. 2007;13:145-47.
22. Zhang P, Chen ZH, Hu JS, Wei BY, Zhang ZG, Hu WQ. Production and characterization of amanitin toxins from a pure culture of Amanita exitialis. FEMS Microbiol Lett. 2005;252:223-28.
23. Hu JS, Chen ZH, Zhang ZG, Zhang P. Analysis of the main amatoxins and phallotoxins in Amanita exitialis-a new species in China. Acta Microbiol Sin. 2003;43:642-46.
24. Yang YB, Hu JS, Chen ZH, Tan NH. Amatoxins from Amanita fuliginea. Nat Product Res Dev. 2003;15:390-2.
25. Deng WQ, Li TH, Xi PG, Gan LX, Xiao ZD, Jiang ZD. Peptide toxin components of Amanita exitialis basidiocarps. Mycologia. 2011;103:946-49.
26. Wei W, Wu XM, Li YJ. Experimental methodology of pharmacology. 4th ed. Beijing: People's Medical Publishing House; 2010.
27. Mengs U, Pohl RT, Mitchell T. Legalon® SIL: the antidote of choice in patients with acute hepatotoxicity from amatoxin poisoning. Curr Pharm Biotechnol. 2012;13:1964-70.
28. Wellington K, Jarvis B. Silymarin: a review of its clinical properties in the management of hepatic disorders. BioDrugs. 2001;15:465-89.
29. Letschert K, Faulstich H, Keller D, Keppler D. Molecular characterization and inhibition of amanitin uptake into human hepatocytes. Toxicol Sci. 2006;91:140-49.
30. Pradhan SC, Girish C. Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine. Indian J Med Res. 2006;124:491-504.
31. Zheleva A, Tolekova A, Zhelev M, Uzunova V, Platikanova M, Gadzheva V. Free radical reactions might contribute to severe alpha amanitin hepatotoxicity-a hypothesis. Med Hypotheses. 2007;69:361-67.
32. Magdalan J, Piotrowska A, Gomulkiewicz A, Sozanski T, Szelag A, Dzidgiel P. Influence of commonly used clinical antidotes on antioxidant systems in human hepatocyte culture intoxicated with alpha-amanitin. Hum Exp Toxicol. 2011;30:38-43.